News

The Pharma Letter1d
Bristol Myers faces new antitrust suit over multiple myeloma drug Pomalyst
US insurance giant Cigna has taken fresh legal action against Bristol Myers Squibb (NYSE: BMY), accusing the drugmaker of ...
Bristol Myers Faces Scrutiny For Allegedly Rigging Market On $2 Billion Cancer Drug
Bristol Myers and Celgene are being sued in an antitrust suit, alleging they used fraud, sham litigation, and reverse ...
Fierce Pharma2d
Déjà vu for Bristol Myers as it faces another anti-competition lawsuit over blockbuster Pomalyst
Two months after Bristol Myers Squibb fended off a lawsuit which accused the drugmaker of using illegal tactics to protect ...
Cigna sues Bristol Myers for alleged monopoly over blockbuster cancer drug
Cigna sued Bristol Myers Squibb on Tuesday, accusing the drugmaker of violating U.S. antitrust law by keeping generic ...
Cigna files antitrust case against Bristol Myers over Pomalyst sales
Cigna (NYSE:CI) on Tuesday filed an antitrust lawsuit accusing Bristol Myers Squibb (NYSE:BMY) of breaching U.S. competition ...
Cigna sues Bristol Myers for alleged monopoly over blockbuster multiple myeloma drug
Cigna sued Bristol Myers Squibb on Tuesday, accusing the drugmaker of violating U.S. antitrust law by keeping generic ...